United Services Automobile Association Uro Gen Pharma Ltd. Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$23.83 - $36.44 $1.21 Million - $1.84 Million	-50,605 Closed	0 $0
Q2 2019 Aug 16, 2019	BUY	$32.75 - $40.35 $15,392 - $18,964	470 Added 0.94%	50,605 $1.82 Million
Q1 2019 May 13, 2019	BUY	$35.47 - $54.55 $645,021 - $991,991	18,185 Added 56.92%	50,135 $1.85 Million
Q4 2018 Feb 13, 2019	BUY	$38.35 - $50.39 $53,191 - $69,890	1,387 Added 4.54%	31,950 $1.38 Million
Q3 2018 Nov 13, 2018	SELL	$41.65 - $51.7 $19,575 - $24,299	-470 Reduced 1.51%	30,563 $1.44 Million

Q2 2018 Aug 10, 2018	SELL	$48.35 - $65.33 $18,518 - $25,021	-383 Reduced 1.22%	31,033 $1.54 Million
Q1 2018 May 14, 2018	BUY	$38.64 - $57.54 $486,864 - $725,004	12,600 Added 66.96%	31,416 $1.56 Million
Q4 2017 Feb 14, 2018	BUY	$27.28 - $43.26 $513,300 - $813,980	18,816	18,816 $700,000

113

24M

46.9K

44.3K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $373M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.